GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

David Petrus IbarsIn the same way weight varies from person to person, so do the best weight loss strategies. While some ...

WASHINGTON – Government health officials warned dieters and body builders Friday to immediately stop using Hydroxycut, a widely sold supplement linked to cases of serious liver damage and at least ...

More human research is still needed to confirm the benefits and safety of most nootropic supplements. None are FDA-approved for brain function. Fish oil, ginkgo biloba, and creatine are three ...

The symptoms of high blood sugar include frequent urination, fatigue, blurry vision, frequent hunger, and tingling in your limbs. Here’s what to do to manage your diabetes.